Webinar: Innovative Antibody Discovery: Exploring the Capabilities of a New High-Throughput Screening (HTS) by Cytometry Platform
Overview
The therapeutic antibody landscape is rapidly growing, offering improved specificity and safety. It is driven by the need for higher specificity, and the potential for a broad range of therapeutics.
However, traditional screening methods can be sample-intensive and slow, with limited multiplexing capabilities. This slows progress in areas such as neurodegenerative disorders, oncology, diabetes, and infectious diseases.
This webinar explores innovative high-throughput cytometry technologies, for swift identification and characterization in therapeutic antibody development. It also highlights multiplexed assay design, competitive binding analysis and functional characterization.
Complete the Form to Access the Webinar
The webinar also discusses:
- How the iQue® HTS Cytometer can be used for broad characterization of antibodies.
- Examples of streamlined, easy-to-follow workflows, which are coupled with high-throughput data acquisition to provide a simple, rapid solution for antibody profiling.
- The introduction of iQue® 5 HTS Cytometer, with its extra flexibility and improved user experience.
Webinar Speaker
Nicola Bevan
Manager of Application Development
Sartorius
Nicola Bevan is a Manager of a Cell Imaging Applications group, working within the European-based BioAnalytics research team. She is involved in the research and development of novel kinetic applications for the iQue® High-Throughput Screening by Cytometry Platform, and the Incucyte® Live-Cell Analysis Systems, expanding their capabilities.
She is a highly experienced cellular pharmacologist with more than 30 years of experience. She has worked within the pharmaceutical and biotechnology industries where she has gained broad experiences in a large pharmaceutical industrial screening department and has supported early drug discovery programs.
